Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Sulfobutylether-β-Cydodextrin (SBECD)

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Sulfobutyl ether beta-cyclodextrin, Sodiumsulphobutylether-beta-cyclodextrin, A880893, Beta-cyclodextrin sulfobutyl ether, sodium salts;sodium sulphobutylether-beta-cyclodextrin, Sbe-afae'a centa' nota inverted exclamation markafasa'a, Afae'adaggeratrade markafa centa centasa nota em leadera inverted exclamation mark-cd
    Molecular Formula
    C50H84Na2O41S2
    Molecular Weight
    1451.3  g/mol
    InChI Key
    RGQYVQYXCZODQW-UHFFFAOYSA-L
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    disodium;4-[[36,37,38,39,40,41,42,43,44,45,46,48,49-tridecahydroxy-5,15,20,25,30,35-hexakis(hydroxymethyl)-47-(4-sulfonatobutoxy)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-10-yl]methoxy]butane-1-sulfonate
    2.1.2 InChI
    InChI=1S/C50H86O41S2.2Na/c51-9-16-36-23(57)29(63)45(78-16)86-38-18(11-53)80-47(31(65)25(38)59)88-40-20(13-55)82-49(33(67)27(40)61)90-42-22(15-76-5-1-3-7-92(70,71)72)84-50(43(35(42)69)77-6-2-4-8-93(73,74)75)91-41-21(14-56)83-48(34(68)28(41)62)89-39-19(12-54)81-46(32(66)26(39)60)87-37-17(10-52)79-44(85-36)30(64)24(37)58;;/h16-69H,1-15H2,(H,70,71,72)(H,73,74,75);;/q;2*+1/p-2
    2.1.3 InChI Key
    RGQYVQYXCZODQW-UHFFFAOYSA-L
    2.1.4 Canonical SMILES
    C(CCS(=O)(=O)[O-])COCC1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(O2)C(C8O)O)CO)CO)CO)CO)CO)CO)OCCCCS(=O)(=O)[O-])O.[Na+].[Na+]
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. Betadex Sulfobutyl Ether Sodium

    2. Captisol

    3. Sbe-beta-cd

    4. Sbe4-beta-cd

    5. Sbe4-beta-cyclodextrin

    6. Sulfobutyl Ether Beta-cyclodextrin

    7. Sulfobutylether-beta-cyclodextrin

    8. Sulfobutylether-betacd

    9. Sulfurbutylether-beta-cyclodextrin

    10. Sulphobutylether-betacd

    2.2.2 Depositor-Supplied Synonyms

    1. Sulfobutyl Ether Beta-cyclodextrin

    2. Sodiumsulphobutylether-beta-cyclodextrin

    3. A880893

    4. Beta-cyclodextrin Sulfobutyl Ether, Sodium Salts;sodium Sulphobutylether-beta-cyclodextrin

    5. Sbe-afae'a Centa' Nota Inverted Exclamation Markafasa'a

    6. Afae'adaggeratrade Markafa Centa Centasa Nota Em Leadera Inverted Exclamation Mark-cd

    2.3 Create Date
    2012-11-27
    3 Chemical and Physical Properties
    Molecular Weight 1451.3 g/mol
    Molecular Formula C50H84Na2O41S2
    Hydrogen Bond Donor Count19
    Hydrogen Bond Acceptor Count41
    Rotatable Bond Count17
    Exact Mass1450.3724830 g/mol
    Monoisotopic Mass1450.3724830 g/mol
    Topological Polar Surface Area663 Ų
    Heavy Atom Count95
    Formal Charge0
    Complexity2460
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count35
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count3
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Excipients

    Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc. (See all compounds classified as Excipients.)